Overview of IV Ketamine Infusion
Intravenous (IV) ketamine infusion is the most extensively studied and widely used method of administering ketamine for psychiatric and pain conditions. In this approach, ketamine is dissolved in a saline solution and delivered directly into the bloodstream through an IV line, allowing for precise dosing and rapid onset of action. Understanding bioavailability helps explain why IV delivery is considered the gold standard.
IV infusion offers several advantages over other delivery routes, including 100% bioavailability (the entire dose reaches the bloodstream), precise control over the rate of administration, and the ability to titrate the dose in real time based on patient response. For these reasons, IV ketamine infusion is often considered the gold standard for ketamine therapy.
The Standard Protocol
For Depression and Psychiatric Conditions
The most widely used protocol for depression, based on the original research studies, involves:
- Dose: 0.5 mg/kg of body weight
- Duration: Infused over 40 minutes
- Frequency: Two to three sessions per week
- Initial series: Six infusions over two to three weeks
- Maintenance: Individualized — typically one infusion every two to six weeks as needed
Some clinics have adopted modified protocols with slightly different dosing or timing based on clinical experience and emerging research. For example, some practitioners start at a lower dose and gradually increase based on tolerability and response.
For Chronic Pain
Pain-focused infusion protocols typically involve:
- Higher doses — Often 0.5 to 1.0 mg/kg per hour
- Longer durations — Infusions may last 2 to 4 hours per session
- Multi-day protocols — For conditions like CRPS, 3 to 5 consecutive days of infusion may be used — see our article on continuous ketamine infusions for more detail
- Inpatient options — Some protocols involve prolonged continuous infusions over several days in a hospital setting
What to Expect Before Treatment
Medical Evaluation
Before beginning IV ketamine therapy, patients undergo a thorough medical and psychiatric evaluation. This typically includes:
- Comprehensive psychiatric history and current symptom assessment
- Review of previous medication trials and responses
- Medical history review, with attention to cardiovascular health, liver function, and history of substance use
- Baseline vital signs and, in some cases, blood work or an electrocardiogram (ECG)
- Discussion of treatment goals, expectations, and potential risks — see who is a good candidate for ketamine therapy for common screening criteria
Preparation
Patients are usually instructed to:
- Fast for 4 to 6 hours before the infusion (to reduce nausea risk)
- Arrange transportation, as driving is not permitted after treatment
- Wear comfortable clothing
- Bring a companion if desired for the post-infusion period
During the Infusion
Setting
IV ketamine infusions are administered in a clinical setting — typically a dedicated ketamine clinic, a psychiatric office equipped with monitoring capabilities, or an outpatient infusion center. The treatment room is usually designed to be calm and comfortable, often with dim lighting, reclining chairs, and the option for patients to listen to music through headphones.
Monitoring
Throughout the infusion, patients are monitored continuously for:
- Blood pressure (measured every 5 to 15 minutes)
- Heart rate and rhythm
- Oxygen saturation
- Level of consciousness
- Subjective experience and any adverse effects
A licensed medical provider is present or immediately available throughout the infusion.
The Experience
During a standard 40-minute infusion for depression, patients typically remain awake and conscious but may experience:
- A floating or weightless sensation
- Mild to moderate dissociation — a sense of detachment from one's body or surroundings
- Altered visual perception — colors may appear brighter, patterns may shift
- Changes in the perception of time — 40 minutes may feel shorter or longer
- Emotional experiences — some patients experience a sense of peace, while others may briefly encounter difficult emotions
- Mild nausea (managed with anti-nausea medication if needed)
The intensity of these effects varies significantly between individuals and can differ from session to session. Most patients find the experience manageable and sometimes meaningful.
After the Infusion
Recovery Period
After the infusion ends, patients remain in the clinic for a monitoring period of approximately 30 to 60 minutes. During this time:
- Vital signs are rechecked to confirm return to baseline
- Dissociative effects gradually resolve
- Staff assess the patient's readiness for discharge
Post-Infusion Period
Patients should expect:
- Mild grogginess or fatigue for a few hours after treatment
- Possible mild headache or nausea (uncommon)
- Gradual improvement in mood, often noticed within hours to a day
- Prohibition on driving, operating machinery, or making important decisions for the remainder of the day
Efficacy and Response Patterns
Research and clinical experience have identified several response patterns:
- Rapid responders — Some patients notice significant improvement after the first or second infusion
- Gradual responders — Others show progressive improvement across the full series of six infusions
- Partial responders — A subset achieves meaningful but incomplete improvement, benefiting from optimization of dose or frequency
- Non-responders — Approximately 30-40% of patients do not achieve a significant response, though protocol adjustments may improve outcomes in some cases
Safety Profile
IV ketamine infusion is generally well-tolerated when administered in a controlled clinical setting. Serious adverse events are rare. The most common side effects — dissociation, nausea, elevated blood pressure, and dizziness — are transient and resolve within one to two hours after the infusion ends.
Contraindications to IV ketamine infusion include uncontrolled hypertension, active psychotic symptoms, unstable cardiovascular disease, known allergy to ketamine, and certain forms of elevated intracranial pressure.
Choosing a Provider
When selecting an IV ketamine provider, patients should look for clinics that employ or are supervised by board-certified physicians. Our guide on how to find a ketamine provider offers detailed advice on evaluating clinics. (psychiatrists, anesthesiologists, or emergency medicine physicians), maintain appropriate monitoring equipment, follow evidence-based protocols, and provide follow-up care including integration with ongoing psychiatric or psychological treatment, such as ketamine-assisted psychotherapy.
References
- StatPearls: Ketamine — Comprehensive clinical reference on ketamine pharmacology, IV administration protocols, and monitoring
- MedlinePlus: Ketamine Injection — National Library of Medicine drug information on intravenous ketamine administration
- Ketamine Pharmacology: An Update — NIH review of ketamine pharmacokinetics including IV bioavailability and dosing considerations
- NIMH: Depression — National Institute of Mental Health overview of depression treatment, including IV ketamine research
Share